ECMO products

Nautilus™ ECMO oxygenator with Balance™ biosurface

<p>The Nautilus™ ECMO oxygenator with Balance™ biosurface, featuring a circular flow-path design, is ready to be incorporated into an ECMO circuit.</p>

Features

Changing the shape of ECMO

View the animation to see how the Nautilus™ ECMO oxygenator can improve long-term gas transfer and is built for durability and long-term performance.1


Circular flow-path technology

The Nautilus™ ECMO oxygenator has a transverse flow-path with a circular profile. Transverse flow minimizes surface contact area while achieving a low blood-side pressure drop. The circular profile eliminates corners where low flow and stasis are known to occur.

Designed for durability and long-term performance, incorporate the Nautilus™ oxygenator into your current ECMO circuit.

Circular shape

Eliminates corners, areas known for clotting
 

The Nautilus™ ECMO oxygenator has a transverse flow-path with a circular profile to minimize surface contact area while achieving a low blood-side pressure drop.

Guided inlet

Reduces velocity changes at the inlet where low flow and stasis may occur

The Nautilus™ ECMO oxygenator has a guided inlet that reduces velocity changes at the inlet where low flow and stasis may occur.

Filling vanes

Aid in even filling and even flow distribution across the membrane

The Nautilus™ Smart ECMO oxygenator is equipped with filling vanes that aid in even filling and even flow distribution across the membrane.

Performance data

Designed for durability and long-term performance1

Blood path pressure drop

This chart shows the blood path pressure drop of the Nautilus™ ECMO oxygenator.

Oxygen transfer

This chart shows the oxygen transfer rate of the Nautilus™ ECMO oxygenator.

Heat exchange performance factor

This chart shows the heat exchange performance factor of the Nautilus™ ECMO oxygenator.

Carbon dioxide transfer

This chart shows the carbon dioxide transfer rate of the Nautilus™ ECMO oxygenator.

Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.